Monsanto Company (MON) Downgraded to Underperform

Monsanto Company (MON) is a leading global provider of agricultural products to farmers. But an intense competitive environment and the company’s huge dependence on a few large customers present a risk to its top line.

Monsanto also faces foreign currency risk since a significant portion of its income comes from outside the U.S. We reiterate our Underperform recommendation on the stock based on weak results for three consecutive quarters. We believe this will continue based on the 2010 guidance provided by management, which is 43% lower than fiscal 2009.

Our long-term Underperform recommendation on the stock indicates that we feel it will perform below the broader market. Our $41.00 target price, 16.4X 2011 EPS, reflects this view.

MONSANTO CO-NEW (MON): Free Stock Analysis Report
Zacks Investment Research

About Zacks Investment Research 1766 Articles

Zacks Investment Research is one of the most highly regarded firms in the investment industry. In 1978 Zacks originated the concept of utilizing earnings estimates revisions to make profitable investment decisions. Zacks offers multiple investment products and services to help investors achieve superior returns.


Be the first to comment

Leave a Reply

Your email address will not be published.